The Caspase-3 activity was strengthened following IMT1 treatment in the CRC cells (Fig. 4H) and apoptosis was activated, which was evidenced by an increased TUNEL-nuclei ratio (Fig. 4I). This evidence concerns the gene CASP3 and colorectal carcinoma.